Characterization of WRSs2 and WRSs3, new second-generation virG(icsA)-based Shigella sonnei vaccine candidates with the potential for reduced reactogenicity.

Vaccine
S BarnoyM M Venkatesan

Abstract

Live, attenuated Shigella vaccine candidates, such as Shigella sonnei strain WRSS1, Shigella flexneri 2a strain SC602, and Shigella dysenteriae 1 strain WRSd1, are attenuated principally by the loss of the VirG(IcsA) protein. These candidates have proven to be safe and immunogenic in volunteer trials and in one study, efficacious against shigellosis. One drawback of these candidate vaccines has been the reactogenic symptoms of fever and diarrhea experienced by the volunteers, that increased in a dose-dependent manner. New, second-generation virG(icsA)-based S. sonnei vaccine candidates, WRSs2 and WRSs3, are expected to be less reactogenic while retaining the ability to generate protective levels of immunogenicity seen with WRSS1. Besides the loss of VirG(IcsA), WRSs2 and WRSs3 also lack plasmid-encoded enterotoxin ShET2-1 and its paralog ShET2-2. WRSs3 further lacks MsbB2 that reduces the endotoxicity of the lipid A portion of the bacterial LPS. Studies in cell cultures and in gnotobiotic piglets demonstrate that WRSs2 and WRSs3 have the potential to cause less diarrhea due to loss of ShET2-1 and ShET2-2 as well as alleviate febrile symptoms by loss of MsbB2. In guinea pigs, WRSs2 and WRSs3 were as safe, immunogenic and efficac...Continue Reading

References

Jan 1, 1990·Advances in Experimental Medicine and Biology·H LoppnowH D Flad
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M L BernardiniP J Sansonetti
Aug 1, 1980·Journal of Bacteriology·B R BochnerB N Ames
Oct 1, 1981·Infection and Immunity·P J SansonettiS B Formal
Jun 1, 1981·Biochemical Society Transactions·O WestphalC Galanos
Nov 1, 1995·The Journal of Infectious Diseases·F R NoriegaM M Levine
Jun 22, 1999·Infection and Immunity·T S CosterT L Hale
Nov 24, 1999·Infection and Immunity·J E SomervilleR P Darveau
Mar 17, 2000·Immunological Reviews·R Medzhitov, C Janeway
Mar 23, 2000·European Journal of Biochemistry·A B SchrommU Seydel
Oct 25, 2000·Trends in Microbiology·R Medzhitov, C Janeway
Apr 9, 2001·Infection and Immunity·M M VenkatesanF R Blattner
Dec 14, 2001·Proceedings of the National Academy of Sciences of the United States of America·S UzzauL Bossi
May 8, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hélène D'HautevillePhilippe J Sansonetti
Jun 20, 2002·Trends in Immunology·Martha Triantafilou, Kathy Triantafilou
Aug 13, 2003·The Pediatric Infectious Disease Journal·Justen H PasswellUNKNOWN Israel Shigella Study Group
Dec 13, 2003·Carbohydrate Research·Martine Caroff, Doris Karibian
Dec 16, 2003·BMC Molecular Biology·Kenan C Murphy, Kenneth G Campellone
Feb 21, 2004·FEMS Microbiology Reviews·Amy V Jennison, Naresh K Verma
May 25, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Amita GuptaEric D Mintz
Jun 3, 2005·Journal of Lipid Research·Asmaa El HamidiMartine Caroff
Jan 21, 2006·Current Treatment Options in Gastroenterology·Susan C Morpeth, Nathan M Thielman

❮ Previous
Next ❯

Citations

Dec 29, 2011·Infection and Immunity·Francisco J Martinez-BecerraWendy L Picking
Feb 20, 2013·Nature Reviews. Gastroenterology & Hepatology·Eileen M BarryMyron M Levine
Aug 7, 2010·Current Opinion in Infectious Diseases·Margaret KosekMaribel Paredes Olortegui
Dec 22, 2012·Expert Review of Vaccines·Ana Isabel CamachoCarlos Gamazo
Feb 24, 2016·Japanese Journal of Infectious Diseases·Cecilia CasabonneClaudia Balagué
May 28, 2014·Human Vaccines & Immunotherapeutics·Nathalie BöhlesMichael Hensel
Oct 22, 2011·Microbiological Research·Aaron DaughertyLaura Runyen-Janecky
Aug 5, 2016·The Indian Journal of Medical Research·Neelam Taneja, Abhishek Mewara
Apr 24, 2014·Therapeutic Advances in Vaccines·Shai Ashkenazi, Dani Cohen
May 6, 2016·Clinical and Vaccine Immunology : CVI·Punnee PitisuttithumLadaporn Bodhidatta
Jun 20, 2020·Gut Microbes·Hyesuk SeoWeiping Zhang
Sep 16, 2020·Archives of Microbiology·Ahtesham Ahmad Shad, Wajahat Ahmed Shad
Jan 17, 2021·Applied Microbiology and Biotechnology·Abolfazl HajialibeigiSeyed Latif Mousavi Gargari
Oct 24, 2020·Langmuir : the ACS Journal of Surfaces and Colloids·Nicole A MontoyaMark B Shiflett

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.